• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: ?

作者信息

Hernaez Ruben, Avila Matias A

机构信息

Gastroenterology and Hepatology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA

Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.

出版信息

Gut. 2023 Jan;72(1):7-9. doi: 10.1136/gutjnl-2022-327132. Epub 2022 Apr 26.

DOI:10.1136/gutjnl-2022-327132
PMID:35474266
Abstract
摘要

相似文献

1
Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: ?肝细胞癌患者免疫检查点抑制剂治疗的免疫基因组分类：？
Gut. 2023 Jan;72(1):7-9. doi: 10.1136/gutjnl-2022-327132. Epub 2022 Apr 26.
2
Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.多灶性肝细胞癌的异质性免疫基因组特征及独特逃逸机制
J Hepatol. 2020 May;72(5):896-908. doi: 10.1016/j.jhep.2019.12.014. Epub 2019 Dec 27.
3
[Chinese multidisciplinary expert consensus on combined immunotherapy based on immune checkpoint inhibitors for hepatocellular carcinoma(2021 version)].《中国肝细胞癌免疫检查点抑制剂联合免疫治疗多学科专家共识（2021年版）》
Zhonghua Gan Zang Bing Za Zhi. 2021 Jul 20;29(7):636-647. doi: 10.3760/cma.j.cn501113-20210604-00261.
4
Programmed Cell Death 1 and Hepatocellular Carcinoma: An Epochal Story.程序性细胞死亡 1 与肝细胞癌：一个划时代的故事。
J Gastrointest Cancer. 2021 Dec;52(4):1217-1222. doi: 10.1007/s12029-021-00758-z. Epub 2021 Dec 11.
5
The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas.免疫异质性对免疫检查点抑制剂治疗多灶性肝细胞癌疗效的影响。
Clin Cancer Res. 2020 Sep 15;26(18):4947-4957. doi: 10.1158/1078-0432.CCR-19-3840. Epub 2020 Jun 11.
6
[Molecular pathogenesis of hepatocellular carcinoma].
Nihon Shokakibyo Gakkai Zasshi. 2011 Aug;108(8):1347-53.
7
Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects.肝细胞癌分子靶向治疗的基础与临床研究
Int J Clin Oncol. 2010 Jun;15(3):234. doi: 10.1007/s10147-010-0090-5. Epub 2010 May 27.
8
A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.一种基于肿瘤发生和免疫浸润指导策略的细胞衰老相关分类器可预测肝细胞癌的预后、免疫治疗反应和候选药物。
Front Immunol. 2022 Nov 15;13:974377. doi: 10.3389/fimmu.2022.974377. eCollection 2022.
9
Immune index: A gene and cell prognostic signature for immunotherapy response prediction in hepatocellular carcinoma.免疫指标：一种用于预测肝细胞癌免疫治疗反应的基因和细胞预后标志物。
Pharmacol Res. 2023 Jan;187:106583. doi: 10.1016/j.phrs.2022.106583. Epub 2022 Nov 26.
10
Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma.构建和验证表观遗传调控因子标志物作为肝癌预后、免疫治疗和化疗的新型生物标志物。
Front Immunol. 2022 Jul 14;13:952413. doi: 10.3389/fimmu.2022.952413. eCollection 2022.

引用本文的文献

1
Expression landscape of epigenetic genes in human hepatocellular carcinoma.人类肝细胞癌中表观遗传基因的表达图谱
J Physiol Biochem. 2025 Jun 12. doi: 10.1007/s13105-025-01095-6.
2
Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on NK cell marker genes to predict prognosis and immunotherapy response in hepatocellular carcinoma.单细胞和批量RNA测序的综合分析基于自然杀伤细胞标记基因鉴定出一种特征，以预测肝细胞癌的预后和免疫治疗反应。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10609-10621. doi: 10.1007/s00432-023-04965-y. Epub 2023 Jun 9.
3
Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview.
基于免疫检查点抑制剂的结直肠癌联合治疗概述
Int J Gen Med. 2023 Apr 26;16:1527-1540. doi: 10.2147/IJGM.S408349. eCollection 2023.
4
Characteristics and long-term mortality of patients with non-MAFLD hepatic steatosis.非 MAFLD 性肝脂肪变性患者的特征和长期死亡率。
Hepatol Int. 2023 Jun;17(3):615-625. doi: 10.1007/s12072-023-10512-1. Epub 2023 Mar 31.